Résumé :
|
[BDSP. Notice produite par INIST-CNRS d6mRR0xV. Diffusion soumise à autorisation]. This article builds on a previous study which found low numbers of patent applications for HIV antiretroviral drugs in African countries. A high level of variation was noted across individual countries, and consequently, the present study has sought to account for sources of the variation through statistical analyses. First, a correlation between the number of patents and HIV infection rate was observed (r=0.448, p
|